Testicular Neoplasms Clinical Trial
Official title:
Sequelae of Treatment in Survivors of Testicular Cancer Creation of a Non-exposed Comparison Group for the Platinum Study
The patients enrolled on this new study will serve as an appropriate comparison group consisting of patients with the diagnosis of germ cell testicular cancer who were cured with surgical resection and did not receive cisplatin-based chemotherapy with a group of patients from another study who did receive cisplatin-based chemotherapy.
Primary Objective
To compare the prevalence of ototoxicity and neurotoxicity in GCT cancer survivors who only
had surgery to a similar population from The Platinum Study (RSRB45410/1305011509) who
received cisplatin-based combination chemotherapy.
Secondary Objective
To compare the prevalence of obesity, hypertension, and use of antidepressants/anxiolytics in
GCT cancer survivors who only had surgery to a similar population from The Platinum Study who
received cisplatin-based combination chemotherapy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00231582 -
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II
|
Phase 2 | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Terminated |
NCT02577172 -
Testicular Cancer and Aerobic and Strength Training
|
N/A | |
Completed |
NCT03403777 -
Avelumab in Refractory Testicular Germ Cell Cancer.
|
Phase 2 | |
Recruiting |
NCT05264337 -
Lymphedema After Urologic Surgery
|
||
Active, not recruiting |
NCT03426865 -
Role of Axumin PET Scan in Germ Cell Tumor
|
||
Completed |
NCT00001270 -
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
|
Phase 1 | |
Completed |
NCT02459132 -
High-Intensity Aerobic Interval Training in Testicular Cancer Survivors
|
N/A | |
Completed |
NCT06309732 -
GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)
|
Phase 2 | |
Terminated |
NCT02499952 -
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
|
Phase 2 | |
Recruiting |
NCT02304575 -
Quality of Life Among Testicular Cancer Survivors
|
N/A | |
Withdrawn |
NCT02492360 -
Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT04122430 -
Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
|
||
Recruiting |
NCT02229916 -
Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
|
||
Completed |
NCT02161692 -
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
|
Phase 2 | |
Completed |
NCT02966509 -
Engagement of Patients With Advanced Cancer
|
N/A | |
Recruiting |
NCT02341989 -
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
|
Phase 3 | |
Completed |
NCT05056688 -
Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors
|
N/A | |
Terminated |
NCT05229900 -
A Study of SGN-ALPV in Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT00123773 -
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
|
Phase 2 |